DSC Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-518
| Closed | -$263K | – | 82 |
|
|
2022
Q3 | $263K | Sell |
518
-216
| -29% | -$110K | 0.27% | 70 |
|
|
2022
Q2 | $399K | Sell |
734
-37
| -5% | -$20.1K | 0.4% | 48 |
|
|
2022
Q1 | $455K | Buy |
771
+358
| +87% | +$211K | 0.16% | 54 |
|
|
2021
Q4 | $276K | Sell |
413
-20
| -5% | -$13.4K | 0.21% | 55 |
|
|
2021
Q3 | $247K | Buy |
433
+23
| +6% | +$13.1K | 0.25% | 52 |
|
|
2021
Q2 | $207K | Sell |
410
-270
| -40% | -$136K | 0.15% | 64 |
|
|
2021
Q1 | $310K | Buy |
+680
| New | +$310K | 0.19% | 53 |
|
|
2020
Q4 | – | Sell |
-493
| Closed | -$218K | – | 50 |
|
|
2020
Q3 | $218K | Buy |
+493
| New | +$218K | 0.15% | 37 |
|
|
2020
Q1 | – | Sell |
-1,166
| Closed | -$379K | – | 70 |
|
|
2019
Q4 | $379K | Buy |
1,166
+215
| +23% | +$69.9K | 0.18% | 41 |
|
|
2019
Q3 | $277K | Buy |
951
+159
| +20% | +$46.3K | 0.05% | 57 |
|
|
2019
Q2 | $233K | Sell |
792
-76
| -9% | -$22.4K | 0.04% | 61 |
|
|
2019
Q1 | $238K | Buy |
+868
| New | +$238K | 0.04% | 57 |
|
|
2018
Q4 | – | Sell |
-1,041
| Closed | -$254K | – | 76 |
|
|
2018
Q3 | $254K | Buy |
+1,041
| New | +$254K | 0.03% | 56 |
|
|
2018
Q2 | – | Sell |
-980
| Closed | -$202K | – | 79 |
|
|
2018
Q1 | $202K | Buy |
+980
| New | +$202K | 0.04% | 64 |
|
|
2016
Q1 | – | Sell |
-1,616
| Closed | -$229K | – | 64 |
|
|
2015
Q4 | $229K | Buy |
+1,616
| New | +$229K | 0.12% | 49 |
|